AspenBio Pharma (APPY) Announces Quarterly Earnings, Beats Expectations By $0.03 EPS
AspenBio Pharma (NASDAQ:APPY) issued its quarterly earnings data on Thursday. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.03, AnalystRatings.Net reports.
AspenBio Pharma (NASDAQ:APPY) opened at 1.67 on Thursday. AspenBio Pharma has a 1-year low of $1.35 and a 1-year high of $3.88. The stock has a 50-day moving average of $2. and a 200-day moving average of $2.26. The company’s market cap is $51.8 million.
AspenBio Pharma, Inc (NASDAQ:APPY) is a bio-pharmaceutical company dedicated to the discovery, development, manufacture, and marketing of products.
Receive News & Ratings for AspenBio Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AspenBio Pharma and related companies with Analyst Ratings Network's FREE daily email newsletter.